🇺🇸 FDA
Patent

US 6284254

Immunogenic compositions comprising cold-adapted attenuated respiratory syncytial virus mutants

expired A61KA61K2039/5254A61K2039/543

Quick answer

US patent 6284254 (Immunogenic compositions comprising cold-adapted attenuated respiratory syncytial virus mutants) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 04 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/5254, A61K2039/543, A61K39/12, A61K39/155